![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1615537 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP703 mRNA | CTD | PMID:36331819 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of ZNF703 mRNA | CTD | PMID:16474171, PMID:32387340 | 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with TGFB1 protein] results in increased expression of ZNF703 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1588249 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP703 mRNA | CTD | PMID:30621213 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1588249 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP703 mRNA | CTD | PMID:32109520 more ... | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | RGD:1588249 | 6480464 | 2 more ... | CTD | PMID:32109520 | 2-hydroxypropanoic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of ZNF703 mRNA | CTD | PMID:30851411 | 4,4'-sulfonyldiphenol | increases expression | ISO | RGD:1615537 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased expression of ZFP703 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects methylation | ISO | RGD:1615537 | 6480464 | bis(4-hydroxyphenyl)sulfone affects the methylation of ZFP703 gene | CTD | PMID:31683443 | 4-hydroxyphenyl retinamide | decreases expression | ISO | RGD:1615537 | 6480464 | Fenretinide results in decreased expression of ZNF703 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | decreases expression | ISO | RGD:1588249 | 6480464 | Propylthiouracil results in decreased expression of ZFP703 mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | RGD:1588249 | 6480464 | acetamide results in increased expression of ZFP703 mRNA | CTD | PMID:31881176 | acrylamide | affects expression | ISO | RGD:1588249 | 6480464 | Acrylamide affects the expression of ZFP703 mRNA | CTD | PMID:28959563 | afimoxifene | multiple interactions | EXP | | 6480464 | afimoxifene inhibits the reaction [Estrogens results in increased expression of ZNF703 mRNA] | CTD | PMID:21233418 | all-trans-retinoic acid | increases expression | ISO | RGD:1615537 | 6480464 | Tretinoin results in increased expression of ZFP703 mRNA | CTD | PMID:16604517 | all-trans-retinoic acid | increases expression | ISO | RGD:1588249 | 6480464 | Tretinoin results in increased expression of ZNF703 mRNA | CTD | PMID:20488242 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ZNF703 mRNA | CTD | PMID:21934132 | amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of ZNF703 mRNA | CTD | PMID:19774075 | amphetamine | increases expression | ISO | RGD:1588249 | 6480464 | Amphetamine results in increased expression of ZFP703 mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ZNF703 mRNA | CTD | PMID:24449571 | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of ZNF703 mRNA | CTD | PMID:33212167 | atrazine | affects methylation | ISO | RGD:1588249 | 6480464 | Atrazine affects the methylation of ZFP703 gene | CTD | PMID:28931070 | benzo[a]pyrene | decreases expression | ISO | RGD:1615537 | 6480464 | Benzo(a)pyrene results in decreased expression of ZFP703 mRNA | CTD | PMID:20713471, PMID:27195522 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZNF703 exon | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:1615537 | 6480464 | Benzo(a)pyrene results in increased expression of ZFP703 mRNA | CTD | PMID:19770486 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A analog results in increased expression of ZNF703 mRNA, bisphenol A results in increased expression of ZNF703 mRNA | CTD | PMID:16474171, PMID:32387340 | bisphenol A | increases expression | ISO | RGD:1615537 | 6480464 | bisphenol A results in increased expression of ZFP703 mRNA | CTD | PMID:32156529, PMID:34585602 | bisphenol A | decreases expression | ISO | RGD:1588249 | 6480464 | bisphenol A results in decreased expression of ZNF703 mRNA | CTD | PMID:25181051 | bisphenol F | increases expression | ISO | RGD:1615537 | 6480464 | bisphenol F results in increased expression of ZFP703 mRNA | CTD | PMID:30951980 | buta-1,3-diene | decreases expression | ISO | RGD:1615537 | 6480464 | 1, 3-butadiene results in decreased expression of ZFP703 mRNA | CTD | PMID:29038090 | C60 fullerene | increases expression | ISO | RGD:1588249 | 6480464 | fullerene C60 results in increased expression of ZFP703 mRNA | CTD | PMID:19167457 | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF703 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF703 mRNA | CTD | PMID:35301059 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZNF703 gene] | CTD | PMID:28238834 | chlorpyrifos | decreases expression | ISO | RGD:1615537 | 6480464 | Chlorpyrifos results in decreased expression of ZFP703 mRNA | CTD | PMID:30621213 | chlorpyrifos | decreases expression | ISO | RGD:1588249 | 6480464 | Chlorpyrifos results in decreased expression of ZFP703 mRNA | CTD | PMID:27905518 | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of ZNF703 mRNA | CTD | PMID:27392435 | clofibrate | decreases expression | ISO | RGD:1615537 | 6480464 | Clofibrate results in decreased expression of ZFP703 mRNA | CTD | PMID:17585979 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | EXP | | 6480464 | Coumestrol results in increased expression of ZNF703 mRNA | CTD | PMID:19167446 | diazinon | increases methylation | EXP | | 6480464 | Diazinon results in increased methylation of ZNF703 gene | CTD | PMID:22964155 | dicrotophos | increases expression | EXP | | 6480464 | dicrotophos results in increased expression of ZNF703 mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZNF703 mRNA | CTD | PMID:29803840 | Enterolactone | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ZNF703 mRNA | CTD | PMID:19167446 | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ZNF703 protein | CTD | PMID:23301498 | epoxiconazole | increases expression | ISO | RGD:1615537 | 6480464 | epoxiconazole results in increased expression of ZFP703 mRNA | CTD | PMID:35436446 | Ethylenethiourea | decreases expression | ISO | RGD:1588249 | 6480464 | Ethylenethiourea results in decreased expression of ZFP703 mRNA | CTD | PMID:27905518 | fenarimol | increases expression | ISO | RGD:1588249 | 6480464 | fenarimol results in increased expression of ZFP703 mRNA | CTD | PMID:28970091 | flusilazole | increases expression | ISO | RGD:1588249 | 6480464 | flusilazole results in increased expression of ZFP703 mRNA | CTD | PMID:28263823 | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of ZNF703 mRNA | CTD | PMID:16474171 | gentamycin | decreases expression | ISO | RGD:1588249 | 6480464 | Gentamicins results in decreased expression of ZFP703 mRNA | CTD | PMID:33387578 | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of ZNF703 mRNA | CTD | PMID:28988120 | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of ZNF703 mRNA | CTD | PMID:33647349 | manganese(II) chloride | increases expression | ISO | RGD:1588249 | 6480464 | manganese chloride results in increased expression of ZFP703 mRNA | CTD | PMID:28801915 | N-methyl-4-phenylpyridinium | decreases expression | ISO | RGD:1588249 | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of ZFP703 mRNA | CTD | PMID:28801915 | p-toluidine | increases expression | ISO | RGD:1588249 | 6480464 | 4-toluidine results in increased expression of ZNF703 mRNA | CTD | PMID:27638505 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ZNF703 mRNA | CTD | PMID:29067470 | paracetamol | increases expression | ISO | RGD:1588249 | 6480464 | Acetaminophen results in increased expression of ZFP703 mRNA | CTD | PMID:32479839, PMID:33387578 | paraquat | decreases expression | ISO | RGD:1588249 | 6480464 | Paraquat results in decreased expression of ZFP703 mRNA | CTD | PMID:32680482 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1615537 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP703 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | ISO | RGD:1615537 | 6480464 | Phenobarbital affects the expression of ZFP703 mRNA | CTD | PMID:23091169 | phenylmercury acetate | increases expression | EXP | | 6480464 | Phenylmercuric Acetate results in increased expression of ZNF703 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF703 mRNA | CTD | PMID:27188386 | propiconazole | increases expression | ISO | RGD:1588249 | 6480464 | propiconazole results in increased expression of ZFP703 mRNA | CTD | PMID:28970091 | prothioconazole | decreases expression | EXP | | 6480464 | prothioconazole results in decreased expression of ZNF703 mRNA | CTD | PMID:35048155 | rac-lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of ZNF703 mRNA | CTD | PMID:30851411 | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ZNF703 mRNA | CTD | PMID:19167446 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | increases expression | ISO | RGD:1615537 | 6480464 | Silicon Dioxide results in increased expression of ZFP703 mRNA | CTD | PMID:19073995, PMID:33720480 | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ZNF703 mRNA | CTD | PMID:34032870 | Soman | increases expression | ISO | RGD:1588249 | 6480464 | Soman results in increased expression of ZFP703 mRNA | CTD | PMID:19281266 | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of ZNF703 mRNA | CTD | PMID:31533062 | thioacetamide | increases expression | ISO | RGD:1588249 | 6480464 | Thioacetamide results in increased expression of ZFP703 mRNA, Thioacetamide results in increased expression of ZNF703 mRNA | CTD | PMID:23411599, PMID:34492290 | triadimefon | increases expression | ISO | RGD:1588249 | 6480464 | triadimefon results in increased expression of ZFP703 mRNA | CTD | PMID:28263823 | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of ZNF703 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF703 mRNA | CTD | PMID:27188386 | triptonide | affects expression | ISO | RGD:1615537 | 6480464 | triptonide affects the expression of ZFP703 mRNA | CTD | PMID:33045310 | troglitazone | increases expression | ISO | RGD:1615537 | 6480464 | troglitazone results in increased expression of ZNF703 mRNA | CTD | PMID:28973697 | tungsten | decreases expression | ISO | RGD:1615537 | 6480464 | Tungsten results in decreased expression of ZFP703 mRNA | CTD | PMID:30912803 | urethane | increases expression | EXP | | 6480464 | Urethane results in increased expression of ZNF703 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of ZNF703 gene | CTD | PMID:29154799 | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZNF703 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of ZNF703 mRNA | CTD | PMID:26272509 | |